AHCO Share Price Performance
US$10.40
0.40 (4.00%)
20.1% undervalued intrinsic discount
US$13.02
Fair Value
Price US$10.40
AnalystConsensusTarget US$13.02
AnalystLowTarget US$10.50
AnalystHighTarget US$16.00
Fair ValueUS$13.13
Share Pricen/a
AdaptHealth Corp. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 9 Fair Values set on narratives written by author
AHCO Community Narratives
AN
Fair Value US$13.13 20.8% undervalued intrinsic discount
Capitated Deal And AI Automation Will Transform Home Healthcare
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AN
Fair Value US$10.5 1.0% undervalued intrinsic discount
CMS Pressure Will Crimp Home Healthcare Yet Tech Aids Recovery
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value US$16 35.0% undervalued intrinsic discount
Aging Population And Remote Monitoring Will Expand Home Healthcare
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Aging Population And Remote Monitoring Will Expand Home Healthcare
Key Takeaways Management anticipates transformative growth from new contracts, tech-driven efficiency, and industry consolidation, positioning AdaptHealth for outsized revenue, market share, and margin expansion. Legislative and demographic shifts, plus expansion into tech-enabled care, are set to unlock new recurring revenue streams and accelerate long-term earnings above market forecasts.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$16
35.0% undervalued intrinsic discount
AnalystHighTarget's Fair Value
Revenue
8.52% p.a.
Profit Margin
5.83%
Future PE
11.21x
Price in 2028
US$20.11
Capitated Deal And AI Automation Will Transform Home Healthcare
Key Takeaways Exclusive long-term contracts, digital automation, and demographic tailwinds are enhancing recurring revenue, operational efficiency, and providing sustained growth opportunities in core segments. Industry consolidation, margin expansion, and improved financial flexibility through disciplined M&A and debt reduction strengthen competitive positioning and long-term earnings potential.Read more
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AN
US$13.13
20.8% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
7.64% p.a.
Profit Margin
3.9%
Future PE
14.04x
Price in 2028
US$16.45
CMS Pressure Will Crimp Home Healthcare Yet Tech Aids Recovery
Key Takeaways Elevated infrastructure expenses and reliance on government reimbursement could suppress margins and cap long-term earnings growth despite strong recurring revenue trends. Shifts toward digital health and remote monitoring may erode demand for core products if AdaptHealth cannot innovate quickly enough to maintain market share.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$10.5
1.0% undervalued intrinsic discount
AnalystLowTarget's Fair Value
Revenue
5.33% p.a.
Profit Margin
4.44%
Future PE
10.52x
Price in 2028
US$13.13
Trending Discussion
Recently Updated Narratives
AN
CMS Pressure Will Crimp Home Healthcare Yet Tech Aids Recovery
Fair Value: US$10.5 1.0% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Aging Population And Remote Monitoring Will Expand Home Healthcare
Fair Value: US$16 35.0% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Capitated Deal And AI Automation Will Transform Home Healthcare
Fair Value: US$13.13 20.8% undervalued intrinsic discount
5 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
AdaptHealth Corp. Key Details
About AHCO
- Founded
- 2012
- Employees
- 10500
- CEO
- WebsiteView website
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. The company offers sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also provides wheelchairs, hospital beds, oxygen concentrators, insulin pumps, CPAP masks and related supplies, diabetes management and wound care supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Plymouth Meeting, Pennsylvania.
